Adelman Burt A
- SEC CIK
- 0001226283
No open-market purchases or sales filed in the past year.
Current role at each company
- VERV Verve Therapeutics, Inc.Directoras of Jul 28, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Adelman Burt A as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 13, 2022 (view filing) | May 12 | 1 day | Adelman Burt ADirector | PPurchase | +10.0K | $12.15 | +$121.5K | +114.9%18.7K after | |
| Mar 17, 2022 (view filing) | Mar 15 | 2 days | Adelman Burt ADirector | PPurchase | +4.00K | $21.38 | +$85.5K | +85.1%8.70K after | |
| Dec 6, 2021 (view filing) | Dec 2 | 4 days | Adelman Burt ADirector | PPurchase | +4.70K | $31.34 | +$147.3K | New position4.70K after |